Cloned (Comment) | Organism |
---|---|
gene MVK, DNA and amino acid sequence determination and analysis, sequence comparisons and phylogenetic analysis, expression and functional complementation of GbMVK in haploid disrupted MVK-deficient Saccharomyces cerevisiae strain DELTAerg12. Quantitative RT-PCR enzyme expression analysis | Ginkgo biloba |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Ginkgo biloba | 5829 | - |
Metals/Ions | Comment | Organism | Structure |
---|---|---|---|
Mg2+ | required | Ginkgo biloba |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + (R)-mevalonate | Ginkgo biloba | - |
ADP + (R)-5-phosphomevalonate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Ginkgo biloba | A0A1S6KJR4 | plant samples obtained from 18-year-old trees of Ginkgo biloba growing in the Ginkgo garden of Yangtze University, Hubei, China (around N30.35, E112.14) | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
leaf | - |
Ginkgo biloba | - |
additional information | GbMVK is highly expressed in leaves and roots, tissue expression pattern analysis, overview. Quantitative RT-PCR enzyme expression analysis | Ginkgo biloba | - |
root | - |
Ginkgo biloba | - |
seedling | - |
Ginkgo biloba | - |
stem | - |
Ginkgo biloba | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ATP + (R)-mevalonate | - |
Ginkgo biloba | ADP + (R)-5-phosphomevalonate | - |
? |
Subunits | Comment | Organism |
---|---|---|
? | x * 42000, about, sequence calculation | Ginkgo biloba |
More | the structure of GbMVK monomer contains a ribosomal protein S5 2-type (8-230), a GHMP kinase N-terminal domain (140-220), and a GHMP kinase C-terminal domain (236-390). Ile146-Ala157 is an ATP-binding conserved site | Ginkgo biloba |
Synonyms | Comment | Organism |
---|---|---|
GbMVK | - |
Ginkgo biloba |
MVK | - |
Ginkgo biloba |
Organism | Comment | pI Value Maximum | pI Value |
---|---|---|---|
Ginkgo biloba | sequence calculation | - |
5.71 |
Organism | Comment | Expression |
---|---|---|
Ginkgo biloba | methyl jasmonate and salicylic acid increase the expression level of GbMVK and enhance the terpene trilactones (TTLs) production in Ginkgo biloba seedlings | up |
General Information | Comment | Organism |
---|---|---|
evolution | GbAACT and GbMVK are highly homologous to AACT genes and MVK genes from other plant species. The structure of GbMVK monomer contains a ribosomal protein S5 2-type (8-230), a GHMP kinase N-terminal domain (140-220), and a GHMP kinase C-terminal domain (236-390). Ile146-Ala157 is an ATP-binding conserved site. Molecular evolution analysis and phylogenetic analysis, overview | Ginkgo biloba |
metabolism | ginkgolides and bilobalides, collectively termed terpene trilactones (TTLs), are terpenoids that form the main active substance of Ginkgo biloba. Terpenoids in the mevalonate (MVA) biosynthetic pathway include acetyl-CoA C-acetyltransferase (AACT) and mevalonate kinase (MVK) as core enzymes, pathways overview. TTL content in Ginkgo biloba can be enhanced by upregulating the transcript levels of some of these genes | Ginkgo biloba |
physiological function | enzyme GbMVK mediates the conversion of mevalonate to mevalonate phosphate and is involved in biosynthesis of ginkgolides and bilobalides, termed terpene trilactones (TTLs), in Ginkgo biloba. GbAACT and GbMVK are functional genes in the cytosolic mevalonate (MVA) biosynthesis pathway | Ginkgo biloba |